MT-401-OTS

Near Add Your Location

Sorting 1 by

Accepting patients

RAPID

A Phase 1 Study of Allogenic Off-the-Shelf Multi-Tumor-Associated Antigen-Specific T Cell Products (MT-401-OTS) Administered to Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndromes (RAPID)
Learn more
  • T Cell (Allogeneic)
  • High Risk
  • Phase 1